Amarin Corp News and Activities

View the org chart displaying its 20 main executives

Most searched biographies at Amarin Corp

• Aaron Berg, President and Chief Executive Officer
• Paul Cohen, Director
• Mark Dipaolo, Director

Create your alert
to follow the executive moves at Amarin Corp.

Amarin Corp has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Amarin Corp

• New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia – Amarin Corp
• Amarin Reports 2026 First Quarter Financial Results – Amarin Corp
• Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 – Amarin Corp
• American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction – Amarin Corp
• Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline – Amarin Corp
• New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientif
• Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology – Amarin Corp
• Amarin Reports Fourth Quarter and Full Year 2025 Financial Results – Amarin Corp
• This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease – Amarin Corp
• Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 – Amarin Corp
• View more press releases Close

Social media about Amarin Corp

• Amarin Corp on Wikipedia, Google News & Yahoo Finance
• Amarin Corp on LinkedIn, X (Twitter) & YouTube